Mark Warnock
University of Michigan · 38 works · 1,512 citations · h-index 17
Top works
- Enzymes and Receptors of Prostaglandin Pathways with Arachidonic Acid-derived Versus Eicosapentaenoic Acid-derived Substrates and Products*
- Visceral Adipose Tissue Inflammation Accelerates Atherosclerosis in Apolipoprotein E–Deficient Mice
- Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
- Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin
- Mechanism of Inactivation of Plasminogen Activator Inhibitor-1 by a Small Molecule Inhibitor
- Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2−/− mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation
- The Preparation and Characterization of Novel Peptide Antagonists to Thrombin and Factor VIIa and Activation of Protease-Activated Receptor 1
- Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin
- The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice
- Characterization of a Novel Class of Polyphenolic Inhibitors of Plasminogen Activator Inhibitor-1
- Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
- Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate
- CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII
- Mapping the interaction of bradykinin 1–5 with the exodomain of human protease activated receptor 4
- Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke
- A potent inhibitor of PAI-1, MDI-2517, mitigates disease severity in a preclinical systemic sclerosis model
- Taming Neonatal Hypoxic–Ischemic Brain Injury by Intranasal Delivery of Plasminogen Activator Inhibitor-1
- Thrombostatin FM compounds: direct thrombin inhibitors – mechanism of action in vitro and in vivo
- Synthesis of Novel Peptide Inhibitors of Thrombin‐induced Platelet Activation
- Novel bis-arylsulfonamides and aryl sulfonimides as inactivators of plasminogen activator inhibitor-1 (PAI-1)